Coenzyme Q₁₀: Clinical Applications in Cardiovascular Diseases

Area of Science:

• Biochemistry
• Cardiology
• Nutritional Science

Background:

• Coenzyme Q10 (CoQ10) is vital for cellular energy transfer and possesses antioxidant properties.
• CoQ10 levels decline with age, certain diseases, and medications, potentially worsening inflammation.
• Depletion of CoQ10 is linked to cardiovascular issues and increased oxidative stress.

Purpose of the Study:

• To review evidence on Coenzyme Q10 (CoQ10) supplementation for cardiovascular diseases (CVDs).
• To assess the clinical impact of CoQ10 on patient health and quality of life in CVDs.
• To evaluate CoQ10's role in managing CVD risk factors like hypertension and dyslipidemia.

Main Methods:

• Systematic review of randomized clinical trials (RCTs).
• Analysis of studies investigating CoQ10 supplementation in patients with heart failure, atrial fibrillation, and myocardial infarction.
• Examination of CoQ10's effects on oxidative stress and inflammatory markers.

Main Results:

• CoQ10 supplementation demonstrated a significant reduction in oxidative stress and inflammatory markers across various cardiovascular conditions.
• Evidence suggests potential benefits for heart failure, atrial fibrillation, and myocardial infarction.
• CoQ10 may positively impact associated risk factors including hypertension, insulin resistance, dyslipidemias, and obesity.

Conclusions:

• Coenzyme Q10 (CoQ10) supplementation shows promise as an adjunct therapy for cardiovascular diseases.
• Further large-scale RCTs are required to solidify the therapeutic role of CoQ10.
• CoQ10 may improve patient outcomes and quality of life in cardiovascular conditions.